Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Sequana to acquire NemaPharm

Aug. 9, 1996

Guilford obtains exclusive rights to drug delivery technology

Aug. 9, 1996

Collaboration on production/delivery system of microbial antigens announced

Aug. 9, 1996

Merck discontinues screening agreement with Martek

Aug. 9, 1996

University of Colorado's ribozyme technology protected by Japanese patent

Aug. 9, 1996

Genomic map development accord signed

Aug. 9, 1996

SIBIA and Cognetix sign conopeptide research collaboration

Aug. 9, 1996

Enzon's SCA protein technology patent extended

July 26, 1996

Synsorb Biotech licenses technology for enteropathogenic E. coli infection treatment

July 26, 1996

StressGen acquires rights to gene therapy technology

July 26, 1996

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...